Literature DB >> 10564216

Activation of the NPY Y5 receptor regulates both feeding and energy expenditure.

J J Hwa1, M B Witten, P Williams, L Ghibaudi, J Gao, B G Salisbury, D Mullins, F Hamud, C D Strader, E M Parker.   

Abstract

Intracerebroventricular (ICV) administration of neuropeptide Y (NPY) has been shown to decrease energy expenditure, induce hypothermia, and stimulate food intake. Recent evidence has suggested that the Y5 receptor may be a significant mediator of NPY-stimulated feeding. The present study attempts to further characterize the role of NPY Y5-receptor subtypes in feeding and energy expenditure regulation. Satiated Long-Evans rats with temperature transponders implanted in the interscapular brown adipose tissue (BAT) displayed a dose-dependent decrease in BAT temperature and an increase in food intake after ICV infusion of NPY. Similar effects were induced by ICV administration of peptide analogs of NPY that activate the Y5 receptor, but not by analogs that activate Y1, Y2, or Y4 receptors. Furthermore, ICV infusion of the Y5 selective agonist D-[Trp(32)]-NPY significantly reduced oxygen consumption and energy expenditure of rats as measured by indirect calorimetry. These data suggest that the NPY Y5-receptor subtype not only mediates the feeding response of NPY but also contributes to brown fat temperature and energy expenditure regulation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564216     DOI: 10.1152/ajpregu.1999.277.5.R1428

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  18 in total

1.  A neuropeptide Y Y5 antagonist selectively ameliorates body weight gain and associated parameters in diet-induced obese mice.

Authors:  Akane Ishihara; Akio Kanatani; Satoshi Mashiko; Takeshi Tanaka; Masayasu Hidaka; Akira Gomori; Hisashi Iwaasa; Naomi Murai; Shin-ichiro Egashira; Takashi Murai; Yuko Mitobe; Hiroko Matsushita; Osamu Okamoto; Nagaaki Sato; Makoto Jitsuoka; Takahiro Fukuroda; Tomoyuki Ohe; Xiaoming Guan; Douglas J MacNeil; Lex H T Van der Ploeg; Masaru Nishikibe; Yasuyuki Ishii; Masaki Ihara; Takehiro Fukami
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-24       Impact factor: 11.205

Review 2.  Peptidylgycine α-amidating monooxygenase and copper: a gene-nutrient interaction critical to nervous system function.

Authors:  Danielle Bousquet-Moore; Richard E Mains; Betty A Eipper
Journal:  J Neurosci Res       Date:  2010-09       Impact factor: 4.164

Review 3.  Role of gastrointestinal hormones in feeding behavior and obesity treatment.

Authors:  Timothy Sean Kairupan; Haruka Amitani; Kai-Chun Cheng; Joshua Runtuwene; Akihiro Asakawa; Akio Inui
Journal:  J Gastroenterol       Date:  2015-09-07       Impact factor: 7.527

4.  NPY Y1 receptor is involved in ghrelin- and fasting-induced increases in foraging, food hoarding, and food intake.

Authors:  Erin Keen-Rhinehart; Timothy J Bartness
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-01-04       Impact factor: 3.619

Review 5.  Hungry for life: How the arcuate nucleus and neuropeptide Y may play a critical role in mediating the benefits of calorie restriction.

Authors:  Robin K Minor; Joy W Chang; Rafael de Cabo
Journal:  Mol Cell Endocrinol       Date:  2008-11-11       Impact factor: 4.102

Review 6.  Neuropeptide Y in normal eating and in genetic and dietary-induced obesity.

Authors:  B Beck
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2006-07-29       Impact factor: 6.237

7.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

8.  A neuropeptide ligand of the G protein-coupled receptor GPR103 regulates feeding, behavioral arousal, and blood pressure in mice.

Authors:  Shinobu Takayasu; Takeshi Sakurai; Satoshi Iwasaki; Hitoshi Teranishi; Akihiro Yamanaka; S Clay Williams; Haruhisa Iguchi; Yuka Imamura Kawasawa; Yukio Ikeda; Iori Sakakibara; Kousaku Ohno; Ryoichi X Ioka; Saori Murakami; Naoshi Dohmae; Jian Xie; Toshihiro Suda; Toshiyuki Motoike; Takashi Ohuchi; Masashi Yanagisawa; Juro Sakai
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-28       Impact factor: 11.205

9.  Fibroblast growth factor 21 is a metabolic regulator that plays a role in the adaptation to ketosis.

Authors:  Eleni M Domouzoglou; Eleftheria Maratos-Flier
Journal:  Am J Clin Nutr       Date:  2011-02-23       Impact factor: 7.045

10.  Neuropeptide Y stabilizes body temperature and prevents hypotension in endotoxaemic rats.

Authors:  Melanie Felies; Stephan von Hörsten; Reinhard Pabst; Heike Nave
Journal:  J Physiol       Date:  2004-09-23       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.